Histone deacetylase
Histone deacetylase (HDAC) is a type of enzyme that plays a crucial role in the regulation of gene expression. HDACs are part of a larger family of proteins that are involved in the modification of histones, the proteins around which DNA is wound to form chromosomes.
Function[edit]
HDACs remove acetyl groups from the histones, which leads to the condensation of the DNA-histone complex and the suppression of gene expression. This process is known as histone deacetylation.
Types[edit]
There are four classes of HDACs:
- Class I includes HDACs 1, 2, 3, and 8. These are found in the nucleus and are involved in cell survival and proliferation.
- Class II includes HDACs 4, 5, 6, 7, 9, and 10. These can shuttle between the nucleus and the cytoplasm and are involved in a variety of cellular processes.
- Class III includes the sirtuins, which are involved in aging and metabolism.
- Class IV includes only HDAC11, which has properties of both Class I and II HDACs.
Role in Disease[edit]
Abnormal HDAC activity has been linked to a number of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. In cancer, for example, increased HDAC activity can lead to the silencing of tumor suppressor genes.
HDAC Inhibitors[edit]
HDAC inhibitors are a class of drugs that block the activity of HDACs. They are being investigated for their potential to treat a variety of diseases, including cancer and neurodegenerative diseases.
See Also[edit]
Histone deacetylase[edit]
-
Phylogenetic tree of histone deacetylases
-
Histone tails set for transcriptional activation
-
Histone tails set for transcriptional repression
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
